Breaking News
October 20, 2018 - Pounds Regained After Weight-Loss Op Can Tell Your Doc a Lot
October 20, 2018 - Sending parents letters to fight childhood obesity doesn’t work
October 20, 2018 - Supervised aerobic exercise can support major depression treatment
October 20, 2018 - Mindfulness-based program effective for reducing stress in infertile women
October 20, 2018 - Molecule capable of halting and reverting neurodegeneration caused by Parkinson’s disease identified
October 20, 2018 - Midazolam-mediated alterations of PER2 expression may have functional consequences during myocardial ischemia
October 20, 2018 - Sweat bees are ideal for studying the genes underlying social behavior
October 20, 2018 - Weight loss success associated with brain areas involved in self-control
October 20, 2018 - KHN’s ‘What the Health?’ Republicans’ preexisting political problem
October 20, 2018 - Research provides a more complete picture of suffering caused by terrorist attacks
October 20, 2018 - Eradicating Helicobacter pylori infections may be a key treatment for Parkinson’s disease
October 20, 2018 - Breast Cancer as a Dynamic Disease
October 20, 2018 - University of Pittsburgh wins NSF grant for big data research to prevent complications from anesthesia
October 20, 2018 - Skin-to-skin contact may promote attachment between parents and preterm infants
October 20, 2018 - Recommendations Developed to Verify NGT Placement in Children
October 20, 2018 - Weight loss can be boosted fivefold thanks to novel mental imagery technique
October 20, 2018 - Children with autism are more likely to be overweight, obese
October 20, 2018 - Nurses making conscientious objections to ethically-relevant policies lack support
October 20, 2018 - Prion strain diversity may be greater than previously thought
October 20, 2018 - Antidepressant treatment may lead to improvements in sleep quality of patients with depression
October 20, 2018 - Study reports increased risk of death in children with inflammatory bowel disease
October 20, 2018 - Number of Autism Genes Now Tops 100
October 20, 2018 - Total diet replacement programmes are effective for treating obesity
October 20, 2018 - CLARIOstar used for fluorescence measurements on CSIRO’s purpose-built research vessel
October 20, 2018 - People with more copies of AMY1 gene digest starchy carbohydrates faster
October 20, 2018 - Case Comprehensive Cancer Center wins NIH grant to study health disparities
October 20, 2018 - Newly discovered compound shows potential for treating Parkinson’s disease
October 20, 2018 - High rate of non-adherence to hormonal therapy found among premenopausal early breast cancer patients
October 20, 2018 - Immunotherapy medicine found to be effective in treating uveitis
October 20, 2018 - The Pistoia Alliance Calls for Greater Collaboration to Realise Benefits of Innovation and Announces Winners of the 2018 President’s Startup Challenge
October 20, 2018 - Female internists consistently earn less than men
October 20, 2018 - Stanford team looks at dangers of teens’ vaping habits
October 20, 2018 - New approach to understanding cancers will accelerate development of better treatments
October 20, 2018 - LJI and UC San Diego awarded $ 4.5 million as part of NCI’s Cancer Moonshot initiative
October 20, 2018 - School-based HPV vaccination did not increase risky sexual behaviors among adolescent girls
October 20, 2018 - Eye discovery to pave way for more successful corneal transplants
October 20, 2018 - New analysis examines the importance of location in the opioid crisis
October 20, 2018 - Green filters increase reading speed for children with dyslexia
October 19, 2018 - Bariatric Sx Cuts Macrovascular Complications in Obesity, T2DM
October 19, 2018 - Better assessments for early age-related macular degeneration
October 19, 2018 - Visible and valued: Stanford Medicine’s first-ever LGBTQ+ Forum | News Center
October 19, 2018 - Understanding of metal-free enzymes used by bacteria could lead to new effective antibiotics
October 19, 2018 - Beckman Coulter Life Sciences announces new research-focused website
October 19, 2018 - Study finds link between refined soluble fibers, gut microbiota and liver cancer
October 19, 2018 - Social media reduces risk of depression among seniors with pain
October 19, 2018 - Newly developed synthetic DNA molecule may one day be used as ‘vaccine’ for prostate cancer
October 19, 2018 - Preoperative weight loss may not provide health benefits after surgery
October 19, 2018 - U.S. Birth Rates Continue to Drop as Age of New Moms Rises
October 19, 2018 - New technology can keep an eye on babies’ movements in the womb
October 19, 2018 - Juul e-cigarettes pose addiction risk for young users | News Center
October 19, 2018 - Gene sequencing reveals crucial molecular aspects of Trypanosoma brucei
October 19, 2018 - New DNA vaccine strategy protects mice against lethal challenge by multiple H3N2 viruses
October 19, 2018 - Study shows close link between cytokine interleukin-1ß and obesity-promoted colon cancer
October 19, 2018 - Muscle mass plays a critical role in health, shows research
October 19, 2018 - Study finds undiagnosed prediabetes in many infertile men
October 19, 2018 - The Current issue of “The view from here” is concerned with Nanotherapeutic strategies
October 19, 2018 - Delay in replacing the Pap smear with HPV screening is costing lives
October 19, 2018 - Physicians battle pediatric diseases of ear, nose, throat in Zimbabwe | News Center
October 19, 2018 - Researchers investigate why some cancers affect only young women
October 19, 2018 - Drugmakers funnel millions to lawmakers; a few dozen get $100,000-plus
October 19, 2018 - Unselfish people tend to have more children and receive higher salaries
October 19, 2018 - New findings reveal potential cellular players in tumor microenvironment
October 19, 2018 - Study reveals impact of Juul use on teenagers and young adults
October 19, 2018 - Green leafy vegetables could help reduce macular degeneration risk
October 19, 2018 - Some countries take more time for reimbursement decisions on new cancer drugs
October 19, 2018 - Human brain cell transplant offers insights into neurological conditions
October 19, 2018 - Parental education associated with increased family health care spending
October 19, 2018 - New statistical method estimates long- and short-term risk of recurrence of breast cancer in US women
October 19, 2018 - Father’s exposure to nicotine may cause cognitive deficits in descendants
October 19, 2018 - Could we prevent Alzheimer’s disease by treating herpes?
October 19, 2018 - Nurse-led care can be more successful in managing gout
October 19, 2018 - Trump administration, pharma exchange verbal volleys on drug-price transparency
October 19, 2018 - Duke researchers find way to detect blood doping in athletes
October 19, 2018 - Many primary care doctors are still prescribing sedative drugs for older adults
October 19, 2018 - Finger length can predict sexuality in women say researchers
October 19, 2018 - Study finds differences in side-effects experienced by male and female OG cancer patients
October 19, 2018 - Dysfunction of single gene leads to miscarriages
October 19, 2018 - Few Seniors Who Self-Harm Referred for Mental Health Care
October 19, 2018 - Don’t sweat the sweet stuff
October 19, 2018 - URMC researchers discover new approach to deliver therapeutics to the brain
Death Rate Falls with Anti-TNF in Crohn’s

Death Rate Falls with Anti-TNF in Crohn’s

image_pdfDownload PDFimage_print

Action Points

  • Patients with Crohn’s disease (CD) treated with tumor necrosis factor (TNF) inhibitors had a statistically significant reduction in mortality relative to those treated with prolonged corticosteroid therapy, in a large retrospective study.
  • Note that the association of anti-TNF therapy and reduced mortality was in the same direction but not statistically significant among patients with ulcerative colitis (UC).

Patients with Crohn’s disease who were treated with tumor necrosis factor (TNF) inhibitors had a lower mortality risk than those who had prolonged corticosteroid therapy, a large retrospective cohort study found.

Among 1,879 Crohn’s patients initiating anti-TNF therapy, there was a significantly lower risk of death (OR 0.78, 95% CI 0.65-0.93) compared with risks for 7,694 patients treated with long-term steroids, according to James D. Lewis, MD, director of the Gastroenterology and Hepatology Clinical Research Program at the University of Pennsylvania in Philadelphia, and colleagues.

And while the mortality risk was numerically lower for patients with ulcerative colitis receiving anti-TNF treatment (n=459), the difference compared with steroid users (n=3,224) was not statistically significant (OR 0.87, 95% CI 0.63-1.22), the researchers reported in the American Journal of Gastroenterology.

“The reduced mortality rates among patients with Crohn’s disease was potentially a consequence of excess cardiovascular-related mortality and hip fractures and was largely limited to patients with multiple or serious comorbid conditions.”

Corticosteroids and anti-TNF therapies both are widely used in the treatment of inflammatory bowel disease, but both approaches are associated with potentially serious — and even fatal — adverse events, the team explained. Both classes of drugs are associated with serious infections and congestive heart failure, anti-TNFs have been linked with cancer, and corticosteroids are associated with pulmonary embolism and osteoporosis/fractures. Moreover, uncontrolled disease may itself raise the mortality risk.

Previous studies have demonstrated an increased mortality risk among patients with inflammatory bowel disease treated with corticosteroids, but studies assessing anti-TNF therapy have not had clear-cut results. Previous work also has not considered potentially important factors such as comorbid illness and older age in evaluating risk of death.

Lewis and colleagues therefore analyzed outcomes among patients with inflammatory bowel disease enrolled in Medicare from 2006 to 2013 and in Medicaid from 2001 to 2005.

The anti-TNF group included those who had at least one prescription for infliximab (Remicade), adalimumab (Humira), or certolizumab pegol (Cimzia) during the previous year, while the prolonged corticosteroid group included those with at least 3,000 mg prednisone or 600 mg of budesonide exposure within the past 12 months.

The primary outcome was all-cause mortality, and secondary endpoints included major adverse cardiovascular events, cancer, hip fracture, pulmonary embolism, serious infection, and emergency bowel resection. The analysis was conducted using marginal structural models and propensity scoring.

Total follow-up times among the Crohn’s disease patients were 6,222 person-years in the anti-TNF group and 24,625 person-years in the prolonged steroid group, while the corresponding numbers for ulcerative colitis were 1,213 and 9,158 person-years, respectively.

During follow-up, 1,444 patients died, with mean ages at death of 67 for patients with Crohn’s disease and 76.7 for those with ulcerative colitis.

The weighted annual incidence of death among patients with Crohn’s disease was 21.4 per 1,000 patients in the anti-TNF group and 30.1 per 1,000 in the prolonged steroid group. For ulcerative colitis, the corresponding numbers were 23 and 30.9 per 1,000, respectively.

The association between anti-TNF use and mortality risk did not differ according to age, but the lower mortality was seen only among patients with comorbidity scores higher than 3, with odds ratios of 0.65 (95% CI 0.48-0.88) for Crohn’s disease and 0.63 (95% CI 0.36-1.11) for ulcerative colitis.

For secondary endpoints among Crohn’s disease patients, anti-TNF therapy was associated with decreased risks of major adverse cardiovascular events (OR 0.68, 95% CI 0.55-0.85) and hip fracture (OR 0.54, 95% CI 0.34-0.83), although these decreased risks were not seen in patients with ulcerative colitis.

The observation that the risk of major adverse cardiovascular events was not decreased in patients with ulcerative colitis may be explained by the fact that systemic inflammation is more common in Crohn’s disease than in ulcerative colitis, the authors noted.

Hospitalizations for inflammatory bowel disease were somewhat more common in the anti-TNF group for both Crohn’s disease (OR 1.13, 95% CI 1.04-1.23) and ulcerative colitis (OR 1.53, 95% CI 1.29-1.81).

The observation that lower mortality rates seen in this analysis appeared to relate to cardiovascular disease and hip fracture as well as to the presence of serious or multiple comorbidities may have implications for treatment, the team said. Such a patient population, “which is rarely included in clinical trials and for whom some physicians may be reluctant to treat with chronic immunosuppression, may be particularly good candidates for anti-TNF agents such as corticosteroid-sparing therapy.”

Limitations of the study, the researchers said, included its residual confounding and reliance on administrative data.

The study was funded by the Patient Centered Outcomes Research Institute (PCORI).

The authors reported financial relationships with Celgene, Shire, Janssen, AbbVie, Immune Pharmaceuticals, AstraZeneca, Amgen, MedImmune, Merck, Nestle Health Science, Takeda, Pfizer, Ili Lilly, Gilead, Samsung Bioepis, Johnson & Johnson, Lycera, Evidera, GlaxoSmithKline, Janssen, Bristol-Myers Squibb, UCB, and Crescendo.

2018-01-24T14:00:00-0500

Tagged with:

About author

Related Articles